Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.

@article{Money1998EffectOC,
  title={Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.},
  author={Samuel R. Money and James Alan Herd and Jonathan L. Isaacsohn and Megan Davidson and Barbara Cutler and James J. Heckman and William P. Forbes},
  journal={Journal of vascular surgery},
  year={1998},
  volume={27 2},
  pages={
          267-74; discussion 274-5
        }
}
PURPOSE This study evaluated the effects of cilostazol on walking distances in patients with intermittent claudication (IC) caused by peripheral arterial occlusive disease. METHODS The study was a multicenter, randomized, double-blind, placebo-controlled trial. Two hundred thirty-nine patients with IC were randomly assigned to receive cilostazol (100 mg b.i.d.) or a placebo for 16 weeks. All patients underwent serial, variable-grade, constant-speed treadmill testing. Absolute claudication… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 97 CITATIONS, ESTIMATED 41% COVERAGE

244 Citations

0102030'98'03'09'15
Citations per Year
Semantic Scholar estimates that this publication has 244 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 21 REFERENCES

Redefining intervention

  • J Isner
  • Circulation
  • 1993

Effects of cilostazol , an antiplatelet drug , on smooth muscle cell proliferation after denudation in rats

  • Y Matsumoto, T Tani, K Watanabe, Y Kimura
  • Jpn J Pharmacol
  • 1992

Similar Papers

Loading similar papers…